JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB91020

Native Human IgA1 protein

Be the first to review this product! Submit a review

|

(9 Publications)

Native Human IgA1 protein is a Human Full Length IgA1 protein with >95% purity and suitable for SDS-PAGE. The predicted molecular weight of ab91020 native protein is 160 kDa.

- Save time and ensure accurate results- use our native IgA1 protein as an isotype control
- No cross-reaction from other immunoglobulin isotypes

View Alternative Names

Immunoglobulin heavy constant alpha 1, Ig alpha-1 chain C region, Ig alpha-1 chain C region BUR, Ig alpha-1 chain C region TRO, IGHA1

1 Images
SDS-PAGE - Native Human IgA1 protein (AB91020)
  • SDS-PAGE

Unknown

SDS-PAGE - Native Human IgA1 protein (AB91020)

SDS-PAGE : 4-12% Bis-Tris NuPAGE gel
1. 5 μg Human IgA1 (reduced /heated)
2. 10 μg Human IgA1 (reduced/ heated)
3. 20 μg Human IgA1 (reduced/ heated)
4. Molecular weight markers
5. 5 μg Human IgA1 (non-reduced/no heat)
6. 10 μg Human IgA1 (non-reduced/no heat)
7. 20 μg Human IgA1 (non-reduced/no heat)

Key facts

Purity

>95% SDS-PAGE

Expression system

Native

Tags

Tag free

Applications

SDS-PAGE

applications

Biologically active

No

Accession

P01876

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 0.87% Sodium chloride

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

The Native Human IgA1 protein ab91020 is prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. No reaction by IEP to IgA2 antiserum.

Ensure the validity of your result using our native human IgA1 protein as an isotype control in SDS-PAGE.

Check out our protein gel staining guide for SDS-PAGE here


Protein Determination: Extinction Coefficient (ε) 0.1% at 280 nm, 1cm pathway = 1.32

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"160 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Native","expressionSystem":null,"accessionNumber":"P01876","tags":[]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

IgA1 also known as Immunoglobulin A1 is an important component of the immune system. This protein mainly exists in mucous membranes where it plays an important role in immune function. IgA1 has a mass of approximately 160 kDa and is expressed in various tissues including the respiratory and gastrointestinal tracts. IgA1 is a subclass of immunoglobulin A (IgA) and is characterized by its heavy chain constant region which distinguishes it from other immunoglobulin subclasses.
Biological function summary

IgA1 acts as a first line of defense in the immune system by binding to pathogens and neutralizing them. It exists as a monomer or forms a dimer with the help of the J chain which stabilizes its dimeric form. IgA1 also interacts with the polymeric immunoglobulin receptor (pIgR) for transportation across epithelial cells. This transport allows IgA1 to be present in secretory fluids such as saliva and breast milk providing an important protective function.

Pathways

IgA1 interacts with several pathways involved in immune response and mucosal immunity. One critical pathway is the mucosal antibody response where IgA1 plays a role in preventing infection at mucosal surfaces. The IgA1 protein activates the alternative complement pathway by binding to complement protein C3 which enhances the removal of pathogens. Furthermore IgA1 is associated with the J chain and pIgR in the process of IgA transcytosis across epithelial barriers.

IgA1 has strong connections to IgA nephropathy and celiac disease. In IgA nephropathy IgA1 deposits in glomeruli leading to inflammation and kidney damage. The increased serum levels of IgA1 often with aberrant glycosylation contribute to disease development. In celiac disease IgA1 reacts with tissue transglutaminase causing an immune response that damages the small intestine's lining. In both disorders the interactions between IgA1 and other proteins such as tissue transglutaminase in celiac disease highlight its involvement in pathological processes.

Specifications

Form

Liquid

General info

Function

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Ig alpha is the major immunoglobulin class in body secretions (PubMed : 2241915).

Post-translational modifications

Isoform 1. 3-Hydroxykynurenine, an oxidized tryptophan metabolite that is common in biological fluids, reacts with alpha-1-microglobulin to form heterogeneous polycyclic chromophores including hydroxanthommatin. The chromophore reacts with accessible cysteines forming non-reducible thioether cross-links with Ig alpha-1 chain C region Cys-352.. N- and O-glycosylated. N-glycan at Asn-144: Hex5HexNAc4.

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Ig alpha is the major immunoglobulin class in body secretions (PubMed : 2241915).
See full target information IGHA1

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Journal of cellular and molecular medicine 29:e70615 PubMed40418206

2025

Exploring the Molecular Mechanism of Hydroxychloroquine Against IgAN Through Network Pharmacology, MD Simulations and Experimental Assessment.

Applications

Unspecified application

Species

Unspecified reactive species

Yuyuan Liu,Jinfang Hu,Jialing Wang,Yanzhe Wang,Gang Wu

Microbiology spectrum :e0245024 PubMed40130864

2025

Group A streptococcal SpeB modifies IgA through targeting regions other than the hinge.

Applications

Unspecified application

Species

Unspecified reactive species

Victoria Vassen,Emi Tanaka,Kirsten Moll,Christian Spoerry,Silvia Synowsky,Sally L Shirran,Ulrich Schwarz-Linek,Edmund Loh,Mattias Svensson,Anna Norrby-Teglund

Oxidative medicine and cellular longevity 2022:1740770 PubMed36388165

2022

Mesangial Cell-Derived Exosomal miR-4455 Induces Podocyte Injury in IgA Nephropathy by Targeting ULK2.

Applications

Unspecified application

Species

Unspecified reactive species

Mengjie Yu,Xiaogang Shen,Wenfang He,Danna Zheng,Qiang He,Juan Jin

Frontiers in pharmacology 13:889008 PubMed35899112

2022

Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaodong Zhu,Xiaogang Shen,Bo Lin,Jiaxi Fang,Juan Jin,Qiang He

Frontiers in medicine 9:881322 PubMed35836957

2022

Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Xia,Di Liu,Haiyang Liu,Liang Peng,Danyi Yang,Chengyuan Tang,Guochun Chen,Yu Liu,Hong Liu

Frontiers in medicine 8:794962 PubMed34977095

2021

Based on Network Pharmacology Tools to Investigate the Mechanism of Against IgA Nephropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Ming Xia,Di Liu,Haiyang Liu,Juanyong Zhao,Chengyuan Tang,Guochun Chen,Yu Liu,Hong Liu

Frontiers in immunology 12:712130 PubMed34804008

2021

Maternal IgA2 Recognizes Similar Fractions of Colostrum and Fecal Neonatal Microbiota.

Applications

Unspecified application

Species

Unspecified reactive species

Erick Sánchez-Salguero,Karina Corona-Cervantes,Hector Armando Guzmán-Aquino,María Fernanda de la Borbolla-Cruz,Víctor Contreras-Vargas,Alberto Piña-Escobedo,Jaime García-Mena,Leopoldo Santos-Argumedo

JCI insight 5: PubMed32699192

2020

TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.

Applications

Unspecified application

Species

Unspecified reactive species

Nuoyan Zheng,Kaifeng Xie,Hongjian Ye,Yu Dong,Bing Wang,Ning Luo,Jinjin Fan,Jiaqing Tan,Wei Chen,Xueqing Yu

Maternal health, neonatology and perinatology 5:9 PubMed31205733

2019

Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum.

Applications

Unspecified application

Species

Unspecified reactive species

Erick Sánchez-Salguero,Geovanni Kaleb Mondragón-Ramírez,Julio C Alcántara-Montiel,Arturo Cérbulo-Vázquez,Xóchitl Villegas-Domínguez,Víctor Manuel Contreras-Vargas,María Del Rocío Thompson-Bonilla,Héctor Romero-Ramírez,Leopoldo Santos-Argumedo
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com